If you have been reading about reversed-phase HPLC and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-04-25. Where a claim depends on a specific study, the study is described rather than over-claimed.
Development of tirzepatide took place under a research program that sought to test whether simultaneous engagement of two incretin receptors would produce greater metabolic effects than single-receptor agonism. Clinical trials were organized into the SURPASS series for type 2 diabetes and the SURMOUNT series for obesity and weight management. Regulatory clearance for type 2 diabetes came in 2022 in the United States, followed by approval for chronic weight management in 2023. The trial programs reported reductions in glycated hemoglobin and body weight relative to comparators, though long-term cardiovascular and durability data continue to accumulate.
The peptide backbone contains 39 amino acids and includes alpha-aminoisobutyric acid residues, which are not among the standard proteinogenic set. A C20 fatty diacid moiety is attached through a linker, allowing the compound to bind serum albumin and extend its circulation time. This albumin binding is the main reason the molecule supports once-weekly administration rather than more frequent dosing. The measured molecular mass is approximately 4,813 daltons, placing it firmly in the peptide rather than small-molecule class.
Tirzepatide is a synthetic peptide of 39 amino acids engineered from the native glucose-dependent insulinotropic polypeptide sequence. Its structure incorporates several non-natural residues and a C-terminal segment derived from glucagon-like peptide-1, together with a C20 fatty diacid moiety attached through a linker. The lipophilic side chain promotes binding to serum albumin, which slows renal clearance after administration. The compound is classified as a dual incretin receptor agonist and is supplied as a lyophilized powder for reconstitution or as a preformulated solution, depending on the presentation.
The peptide activates two G protein-coupled receptors, GIPR and GLP-1R. Binding triggers adenylyl cyclase activity and raises intracellular cyclic AMP in pancreatic beta cells, which potentiates insulin release when glucose is elevated. Signaling in the central nervous system is associated with reduced appetite and lower energy intake, while effects on gastric emptying and glucagon secretion are also reported. Because activity at both receptors is retained, the pharmacological profile is often described as incretin-based rather than selective for a single receptor.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Modified synthetic peptide | 39-residue backbone with non-natural residues |
| Receptor targets | GIP and GLP-1 | Dual incretin receptor agonist |
| Approximate molecular mass | 4,813 Da | Calculated from the peptide sequence |
| Administration route | Subcutaneous injection | Weekly schedule in approved products |
| Albumin binding | Present | Mediated by a C20 fatty diacid side chain |
The peptide shares degradation routes common to modified peptides: deamidation of asparagine and glutamine residues, oxidation of methionine, and backbone hydrolysis under extreme pH. Lyophilized material is generally more stable than a solution, and residual water content directly affects the rate of hydrolysis. In liquid form, aggregation and visible particles can appear after agitation or repeated freeze-thaw cycles. Stability studies therefore track monomer content, aggregate content, and potency over months under defined temperature and humidity.
Cold-chain handling is standard for formulated product, with dry powder stored frozen and ready-to-use solutions refrigerated. Light exposure is minimized because photodegradation of certain amino acid side chains is possible. Shipping and temperature-excursion studies are used to establish whether short deviations affect quality attributes. Documentation supplied with research material usually includes a certificate of analysis listing purity, identity confirmation, and water or residual solvent content. Users are expected to confirm that material meets the stated specification before use.
Identity and purity of tirzepatide are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry. Because the molecule carries several modifications, gradient conditions are adjusted to resolve the intact peptide from deamidation and oxidation products. Enzymatic digestion followed by peptide mapping confirms the primary sequence and locates specific modifications. Quantitation in biological matrices typically uses liquid chromatography with tandem mass spectrometry after solid-phase extraction. Immunoassays are used less often, since antibody cross-reactivity with closely related peptides can bias results.
Research-grade material circulates through suppliers that differ widely in documentation and testing practice, so a certificate of analysis is a starting point rather than proof of quality. Independent verification typically repeats chromatographic purity and mass confirmation on the received lot, and compares results against a retained reference standard. Regulatory status varies by jurisdiction, and a substance cleared as a medicine is not interchangeable with a research chemical of the same name. Open questions include how closely non-pharmaceutical lots match approved material in impurity profile and in aggregate content.
Solid tirzepatide is handled as a lyophilised, hygroscopic peptide powder that should be kept desiccated, protected from light, and stored frozen, typically at or below minus twenty degrees Celsius for long-term retention. Material left at ambient temperature for extended periods can take up moisture, which promotes aggregation and deamidation. Commercial liquid presentations are kept refrigerated between two and eight degrees Celsius and are not frozen. Reconstituted laboratory solutions are generally held cold and used within a short window because hydrolysis and oxidation continue slowly in solution.
Identity and purity are usually established with reversed-phase high-performance liquid chromatography for the main peak and with mass spectrometry for the observed molecular mass. Peptide mapping after enzymatic digestion confirms the primary sequence, while amino acid analysis provides a quantitative composition check. Size-exclusion chromatography and ion-exchange chromatography are used to look for aggregates and charge variants. Water content, residual solvents, and counter-ion content are measured separately, since a lyophilised powder is often reported on an as-is basis unless a correction is applied.
Degradation pathways for tirzepatide include deamidation, oxidation, and aggregation, which are common for therapeutic peptides. These processes can be monitored by size-exclusion chromatography (SEC) for aggregates and ion-exchange chromatography for charge variants. Forced degradation studies under acidic, basic, oxidative, and thermal stress help identify potential impurities. The exact stability profile depends on formulation, concentration, and container-closure system.
Analytical characterization of tirzepatide typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) for purity assessment and peptide mapping. Mass spectrometry, often coupled with electrospray ionization, confirms molecular weight and sequence integrity. Amino acid analysis and capillary electrophoresis may also be used to detect impurities or degradation products. These methods are essential for batch release and stability studies.
=== Mechanism of action === Dasiglucagon operates through the same mechanism as endogenous glucagon, acting as an agonist at glucagon receptors expressed throughout the body, which are G-coupled receptors. Binding to liver glucagon receptors, dasiglucagon activates Gsα and Gq, resulting in the activation of adenylate cyclase. This, in turn, increases intracellular cyclic AMP levels, stimulating glycogenolysis and gluconeogenesis in the liver. As glucose is primarily released from liver glycogen stores, the presence of glycogen stores in the liver is essential for dasiglucagon to exert its antihypoglycemic effects
==== Frogs (Anura) ==== Taudactylus pleione, Kroombit tinker frog (2023) Leptobrachium leishanense, Leishan Moustache toad (2019) Limnodynastes dumerilii dumerilii, Eastern banjo frog (2020) Nanorana parkeri, High Himalaya frog (2015) Oophaga pumilio, Strawberry poison-dart frog (2018) Platyplectrum ornatum, Ornate burrowing frog (2021) Pyxicephalus adspersus, African bullfrog (2018) Rana [Lithobates] catesbeiana, North American bullfrog (2017) Rana kukunoris, Plateau brown frog (2023) Rhinella marina, Cane toad (2018) Vibrissaphora ailaonica, Moustache toad (2019) Xenopus tropicalis, western clawed frog (2010) Mixophyes australis, Australian southern stuttering frog (2024) Spea multiplicata, spadefoot toad (2019) Pelobates cultripes, Western spadefoot toad (2022) Dendrobates tinctorius, Dyeing poison frog (2024) Ranitomeya imitator, mimic poison frog (2024) Phyllobates terribilis, Dart-poison frog (2025) Staurois parvus, foot-flagging frog (2023)
=== Clinical examination === Nipple pain is a symptom with many possible causes. A thorough maternal breast and infant mouth inspection can help identify the specific cause and thus assign the appropriate treatment. A maternal nipple examination can be used to diagnose traumatic factors including nipple fissure, nipple blisters and infections with prominent symptoms. A breast biopsy detecting breast mass can diagnose for breast engorgement. If a breast mass is present, a core needle biopsy and diagnostic imaging are required for further assessment of underlying causes, including mastitis, blocked milk ducts, cancers and benign breast tumours called lactating adenoma. By checking the infant mouth, causes like tongue-tie, candidiasis and abnormal tongue motion can be diagnosed.
Sources: en.wikipedia.org
Despite the health risks in certain cases, the nut-like kernels of the seeds are esteemed in Asia and are a traditional ingredient in Chinese food. Ginkgo nuts are used in congee, and are often served at special occasions such as weddings and the Chinese New Year (as part of the vegetarian dish called Buddha's delight). Japanese cooks add ginkgo seeds (called ginnan) to dishes such as chawanmushi, and cooked seeds are often eaten along with other dishes. Grilled ginkgo nuts with salt are also a popular item at izakayas as a snack with beer and other Japanese food. In Korea, ginkgo nuts are stir-fried and eaten, or are used to garnish foods such as sinseonro.
"Machine Cleans Blood While You Wait"—1950 article on early use of dialysis machine at Bellevue Hospital New York City—an example of how complex and large early dialysis machines were Home Dialysis Museum—History and pictures of dialysis machines through time Introduction to Dialysis Machines—Tutorial describing the main subfunctions of dialysis systems. "First Nations man conducts own dialysis treatments to avoid move to the city"—CBC News (November 30, 2016)
That's why the Gaza law is different here." In Gaza, a father whose one-year-old child was killed in an Israeli bombing stated, "This is a crime in which everyone participated. The US veto participated in this crime as did those Arabs and Muslims who failed to support us". The grandfather of children killed by an Israeli airstrike stated, "What wrong did those innocent children do? Were they posing any danger to Israel? Were they carrying arms?" Marc Owen Jones wrote in a 2025 research paper, "As Israel's killing of thousands of Palestinian children and babies became harder to hide, high-profile Israeli accounts and media outlets claimed that Palestinians were fabricating casualty numbers and staging the killing of babies. The so-called 'Pallywood' narrative – a derogatory term suggesting that Palestinians stage scenes of suffering for propaganda purposes – has been a recurring theme in disinformation campaigns against Gaza."
=== Modern occurrence === During the post Civil war period in Spain, there were several outbreaks of lathyrism, caused by the shortage of food, which led people to consume excessive amounts of almorta flour. In Spain, a seed mixture known as comuña consisting of Lathyrus sativus, L. cicera, Vicia sativa and V. ervilia provides a potent mixture of toxic amino acids to poison monogastric (single stomached) animals. Particularly the toxin β-cyanoalanine from seeds of V. sativa enhances the toxicity of such a mixture through its inhibition of sulfur amino acid metabolism (conversion of methionine to cysteine leading to excretion of cystathionine in urine) and hence depletion of protective reduced thiols. Its use for sheep does not pose any lathyrism problems if doses do not exceed 50 percent of the ration.
Sources: en.wikipedia.org
However, it may have been for religious reasons, and would coincide with the development of religious practices thought to have occurred during the Upper Paleolithic. Nonetheless, it remains possible that Paleolithic societies never practiced cannibalism, and that the damage to recovered human bones was either the result of excarnation or predation by carnivores such as saber-toothed cats, lions, and hyenas. A modern-day diet known as the Paleolithic diet exists, based on restricting consumption only to those foods presumed to be available to anatomically modern humans prior to the advent of settled agriculture.
== Activities == The activity in Chromatography spans HPLC, LC/MS, FPLC, MPLC - GC, GC/MS, GPC, GFC - RMN - AA, IR, ICP, UV – SPE. Interchim notably introduced new generation silica chromatography media (UptiSphere that has become a standard worldwide, Strategy, Atoll). The activity in Fine Chemistry deals with compounds libraries (Chirals, Fluorines, Building blocks for Combi-Chemistry) and flash chromatography. Interchim developed a unique flash chromatography system (PuriFlashEvo430 - integrated functions). The activity in BioSciences focuses on Immunodetection, Biochemistry, Electrophoresis and Cell Assays. Interchim manufactures protein assays (BC Assay, Coo Assay), superior fluorescent dyes known as FluoProbes, Cell Assays reagents and kits (i.e. FluoProbes indicators, high sensitive viability assay UptiBlue) and an innovate transfection agent UptiFectin.
New Brunswick was in turn split from Nova Scotia as part of a reorganization of Loyalist settlements in the Maritimes, which led to the incorporation of Saint John, New Brunswick, as Canada's first city. To accommodate the influx of English-speaking Loyalists in Central Canada, the Constitutional Act of 1791 divided the Province of Quebec into French-speaking Lower Canada (later Quebec) and English-speaking Upper Canada (later Ontario), granting each its own elected legislative assembly.
=== For injury to muscle or joint === For both muscle and joint injuries, it is common to alternate both cold and warm compresses to manage inflammation. Non-steroidal anti-inflammatory drugs and corticosteroids may also be used in conjunction.
== Publications == Derivatives of Columbium and Tantalum, J. Am. Chem. Soc. 1896, 18, 1, 38–67, January 1, 1896 Studies of Poultry from the Farm to the Consumer, Washington, D.C.: U.S. Department of Agriculture, 1910 The Refrigeration of Dressed Poultry in Transit, U.S. Department of Agriculture, 1913 How to Kill and Bleed Market Poultry, Washington D.C.: U.S. Government Printing Office, 1915 A Study of the Preparation of Frozen and Dried Eggs in the Producing Section, Washington, D.C.: U.S. Department of Agriculture, 1916 How to Candle Eggs, Washington D.C.: U.S. Department of Agriculture, 1918 The Prevention of Breakage of Eggs in Transit When Shipped in Carlots, Washington, D.C.: U.S. Department of Agriculture, 1918
Sources: en.wikipedia.org
It binds and activates both the GIP and GLP-1 receptors, making it a dual incretin receptor agonist. Single-receptor GLP-1 agonists act on one target only. The dual profile is the defining pharmacological feature of the molecule.
A fatty diacid side chain promotes reversible binding to serum albumin. This association slows renal clearance and protects the peptide from rapid enzymatic degradation. The result is a prolonged circulation time that supports weekly administration.
The first regulatory approval, for type 2 diabetes, was granted in the United States in 2022. An additional approval for chronic weight management followed in 2023. Availability and approved indications vary by country and are set by each national regulator.
It is a synthetic linear peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It combines a modified incretin backbone with a fatty diacid side chain that extends its circulation time. It is not a small-molecule drug and is not orally absorbed in its native form.